Form 8-K - Current report:
SEC Accession No. 0001698530-25-000071
Filing Date
2025-08-04
Accepted
2025-08-04 16:49:55
Documents
14
Period of Report
2025-08-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20250804.htm   iXBRL 8-K 24388
2 EX-99.1 aex991pressreleaseaug42025.htm EX-99.1 5762
6 exicureimage1a10a.gif GRAPHIC 2794
  Complete submission text file 0001698530-25-000071.txt   153950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250804.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250804_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250804_pre.xml EX-101.PRE 13050
16 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250804_htm.xml XML 2813
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 251181137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)